Page last updated: 2024-10-17

lactic acid and Fractures, Compound

lactic acid has been researched along with Fractures, Compound in 2 studies

Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"Biodegradable poly([D,L]-lactide-co-glycolide) (PLGA) nanofibrous membrane embedded with two drug-to-polymer weight ratios, namely 1:3 and 1:6, which comprised PLGA 180 mg, lidocaine 20 mg, vancomycin 20 mg, and ceftazidime 20 mg, and PLGA 360 mg, lidocaine 20 mg, vancomycin 20 mg, and ceftazidime 20 mg, respectively, was produced as an artificial periosteum in the treatment of segmental femoral fractures."3.83A bio-artificial poly([D,L]-lactide-co-glycolide) drug-eluting nanofibrous periosteum for segmental long bone open fractures with significant periosteal stripping injuries. ( Cheng, YS; Chou, YC; Hsu, YH; Liu, SJ; Yu, YH, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chou, YC1
Cheng, YS1
Hsu, YH1
Yu, YH1
Liu, SJ1
Rajasekaran, S1
Giannoudis, PV1

Other Studies

2 other studies available for lactic acid and Fractures, Compound

ArticleYear
A bio-artificial poly([D,L]-lactide-co-glycolide) drug-eluting nanofibrous periosteum for segmental long bone open fractures with significant periosteal stripping injuries.
    International journal of nanomedicine, 2016, Volume: 11

    Topics: Animals; Ceftazidime; Drug Carriers; Femoral Fractures; Fractures, Open; Lactic Acid; Lidocaine; Mem

2016
Open injuries of the lower extremity: issues and unknown frontiers.
    Injury, 2012, Volume: 43, Issue:11

    Topics: Amputation, Surgical; Biomarkers; Developing Countries; Disabled Persons; Female; Fractures, Open; H

2012